Skip to main content
Clinical Trials/ISRCTN67674151
ISRCTN67674151CompletedNot Applicable

A nurse-led intervention to enhance medication adherence in ulcerative colitis (UC) using a concordance-led consultation

orthern Primary Care Research Network (NoReN) (UK)0 sites106 target enrollmentStarted: April 28, 2004Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
106

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •Adults aged over 16 years with a diagnosis of ulcerative colitis (histologically proven), whose disease has been present for at least one year and who are found, from prescribing records, to be taking aminosalicylate (ASA) therapy at suboptimal levels (defined as using anything less than 8 months supply of aminosalicylates in a 12 month period). Patients who have been specifically told to stop taking their 5ASA medication will be screened out at the stage of initial patient invitation. Eligible patients who subsequently undergo total colectomy and therefore no longer require 5ASA therapy will no longer be eligible for inclusion in the study and will be classified as 'drop-out'.

Exclusion Criteria

  • •Patients with self-limiting colitis or those whose UC has been diagnosed in the past year will be excluded. Patients aged less than 16 years are not eligible for inclusion and patients with significant neurological impairment such that they could not participate in the consultation will also be excluded.

Investigators

Sponsor
orthern Primary Care Research Network (NoReN) (UK)

Similar Trials